What does CUSIP 71426VAK4 represent in this 13F holders report?

CUSIP 71426VAK4 is the security identifier for 71426VAK4 - PERNIX THERAPEUTICS HLDGS IN - DBCV 4.250% 4/0 used to aggregate holder disclosures.

How many institutions held 71426VAK4 - PERNIX THERAPEUTICS HLDGS IN - DBCV 4.250% 4/0 in Q2 2019?

No institutional holders were reported for 71426VAK4 - PERNIX THERAPEUTICS HLDGS IN - DBCV 4.250% 4/0 in Q2 2019; review adjacent reporting periods for trend context.

PERNIX THERAPEUTICS HLDGS IN - DBCV 4.250% 4/0

CUSIP: 71426VAK4

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Debt / DBCV 4.250% 4/0
Total 13F principal: $0
Principal change: -$4,000,000
Total reported market value: $0
Number of holders: 0
Value change: -$46,000
Number of sells: 2

Quarterly Holders Quick Answers

What is CUSIP 71426VAK4?
CUSIP 71426VAK4 identifies 71426VAK4 - PERNIX THERAPEUTICS HLDGS IN - DBCV 4.250% 4/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q1 2019

Recent filing periods for CUSIP 71426VAK4:

Q2 2019 Q1 2019 Q4 2018 Q3 2018 Q2 2018 Q1 2018 Q4 2017 Q3 2017

PERNIX THERAPEUTICS HLDGS IN - DBCV 4.250% 4/0

Q2 2019 13F Holders as of 30 Jun 2019

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of PERNIX THERAPEUTICS HLDGS IN - DBCV 4.250% 4/0 as of Q2 2019.